TY - JOUR
T1 - Negative regulation of cytokine signaling and inflammatory diseases
AU - Inagaki-Ohara, Kyoko
AU - Hanada, Toshikatsu
AU - Yoshimura, Akihiko
PY - 2003/8
Y1 - 2003/8
N2 - Immune and inflammatory systems are controlled by multiple cytokines, including interleukins and interferons. These cytokines exert their biological functions through Janus tyrosine kinases and signal transducer and activators of transcription (STATs). The cytokine-inducible SH2 proteins (CIS) and suppressors of cytokine signaling (SOCS) are a family of intracellular proteins, several of which have emerged as key physiological regulators of cytokine responses, including those that regulate the inflammatory system. Several recent advances have been made in this field, including treatment of inflammatory diseases by modulating extracellular and intracellular signaling pathways.
AB - Immune and inflammatory systems are controlled by multiple cytokines, including interleukins and interferons. These cytokines exert their biological functions through Janus tyrosine kinases and signal transducer and activators of transcription (STATs). The cytokine-inducible SH2 proteins (CIS) and suppressors of cytokine signaling (SOCS) are a family of intracellular proteins, several of which have emerged as key physiological regulators of cytokine responses, including those that regulate the inflammatory system. Several recent advances have been made in this field, including treatment of inflammatory diseases by modulating extracellular and intracellular signaling pathways.
UR - http://www.scopus.com/inward/record.url?scp=0041302153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0041302153&partnerID=8YFLogxK
U2 - 10.1016/S1471-4892(03)00070-5
DO - 10.1016/S1471-4892(03)00070-5
M3 - Review article
C2 - 12901954
AN - SCOPUS:0041302153
SN - 1471-4892
VL - 3
SP - 435
EP - 442
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
IS - 4
ER -